AU2517499A - Use of diphenylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of movement disorders - Google Patents

Use of diphenylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of movement disorders

Info

Publication number
AU2517499A
AU2517499A AU25174/99A AU2517499A AU2517499A AU 2517499 A AU2517499 A AU 2517499A AU 25174/99 A AU25174/99 A AU 25174/99A AU 2517499 A AU2517499 A AU 2517499A AU 2517499 A AU2517499 A AU 2517499A
Authority
AU
Australia
Prior art keywords
medicament
manufacture
treatment
movement disorders
piperidine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25174/99A
Inventor
Jonathan Huw Conninck
Duncan Robertson Rae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU2517499A publication Critical patent/AU2517499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
AU25174/99A 1998-01-09 1999-01-05 Use of diphenylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of movement disorders Abandoned AU2517499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98200039 1998-01-09
EP98200039 1998-01-09
PCT/EP1999/000143 WO1999034799A1 (en) 1998-01-09 1999-01-05 Use of diphenylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of movement disorders

Publications (1)

Publication Number Publication Date
AU2517499A true AU2517499A (en) 1999-07-26

Family

ID=8233287

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25174/99A Abandoned AU2517499A (en) 1998-01-09 1999-01-05 Use of diphenylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of movement disorders

Country Status (2)

Country Link
AU (1) AU2517499A (en)
WO (1) WO1999034799A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540780A (en) * 1983-06-02 1985-09-10 Warner-Lambert Company Diphenylmethylene piperidines
GB9512129D0 (en) * 1995-06-15 1995-08-16 Smithkline Beecham Plc Compounds
IL118768A (en) * 1995-07-12 2000-10-31 Akzo Nobel Nv Diphenylmethane piperidine derivatives pharmaceutical compositions containing them and a method for their preparation

Also Published As

Publication number Publication date
WO1999034799A1 (en) 1999-07-15

Similar Documents

Publication Publication Date Title
IL174732A0 (en) Use of crystal modification of a n-phenyl-2-pyrimidineamine derivative in the preparation of a medicament for the treatment of restenosis
AU1107500A (en) Tooth path treatment plan
AU4342997A (en) Use of quinazoline derivatives for the manufacture of a medicament in the reatment of hyperproliferative skin disorders
PL350984A1 (en) 1,4−benzothiazepine−1,1−dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof
AU6132596A (en) Piperidine and morpholine derivatives and their use as therapeutic agents
AU5732699A (en) Corneal onlay
EP1600169A3 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
AU4060599A (en) Pharmaceutical composition for treating or preventing sleep disorders
AU3162001A (en) Medicament, a method for its production and the use thereof
EP1191941A4 (en) A method for the prophylaxis and/or treatment of medical disorders
AU3142400A (en) A pharmaceutical composition for treating angiocardiopathy and the method of producing thereof
AU6043600A (en) Use of an angiotensin ii type 1 receptor antagonist in the manufacture of a medicament for the treatment of cardiovascular complications
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
CA2260863A1 (en) Treatment of psychotic disorders
AU2620600A (en) Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
AU4443599A (en) Therapeutic bed
AU2517499A (en) Use of diphenylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of movement disorders
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
AU2716599A (en) Use of phenylthienylmethylene piperidine derivative in the manufacture of a medicament for the treatment of movement disorders
AU2719801A (en) Use of ngf for the manufacturing of a drug for treating allergic disorders
AU2279099A (en) Use of diphenylmethylene piperidine derivatives in the manufacture of a medicament for the treatment of depression
AU3071899A (en) Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
AU3071999A (en) Use of pkc inhibitors for the manufacture of a medicament for the treatment of autoimmune diseases
AU1230201A (en) 27875 a human adam-ts homolog

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase